Related Experiment Video
Updated: Jun 6, 2026
09:14
An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
Published on: January 26, 2019
[The malaria vaccine candidate RTS,S/AS is in phase III clinical trials].
1GlaxoSmithKline Biologicals, rue de l'Institut 89, Rixensart, Belgium. joe.cohen@gskbio.com
Annales Pharmaceutiques Francaises
|November 16, 2010
Summary
The RTS,S/AS malaria vaccine, targeting the circumsporozoite protein (CSP), shows promise for public health. Phase III trials are underway, building on over 20 years of research and development.
Area of Science:
- Vaccinology
- Parasitology
- Immunology
Context:
- Malaria remains a significant global health challenge, particularly in sub-Saharan Africa.
- The development of effective malaria vaccines is a critical public health priority.
- The circumsporozoite protein (CSP) of Plasmodium falciparum is a key target for malaria vaccine strategies.
Purpose:
- To review the development of the RTS,S/AS malaria vaccine candidate.
- To describe the rationale for CSP antigen selection and preclinical vaccine history.
- To summarize findings from Phase I/II trials and the progression to Phase III testing.
Summary:
- The RTS,S/AS vaccine development spans over two decades, focusing on the CSP antigen.
- Phase I/II studies demonstrated a favorable safety profile and good tolerability in children and adults.
- Consistent efficacy against Plasmodium falciparum infection and disease was observed in infants and children across various settings.
Impact:
- The RTS,S/AS01(E) vaccine has entered Phase III trials, representing a major milestone in malaria vaccine development.
- Positive Phase III results could lead to significant public health impact in malaria-endemic regions.
- Integration with existing malaria control measures could enhance the vaccine's effectiveness.
Related Concept Videos
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
00:58Symbiosis
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...